AMGN | Amgen Inc | $249.4b | $466.56 | +0.1% | 634.5K |
VRTX | Vertex Pharmaceuticals Inc | $134.5b | $535.57 | -0.3% | 397.8K |
UTHR | United Therapeutics Corp | $25.8b | $585.82 | -0.8% | 174.4K |
INCY | Incyte Genomics Inc | $24.0b | $120.21 | -0.6% | 488.4K |
INSM | Insmed, Inc. | $22.9b | $123.65 | +1.8% | 1.3M |
ALNY | Alnylam Pharmaceuticals, Inc. | $21.4b | $160.18 | -2.8% | 914.8K |
BBIO | BridgeBio Pharma, Inc. Common Stock | $14.4b | $77.05 | -1.6% | 473.7K |
BMRN | BioMarin Pharmaceuticals Inc | $10.8b | $58.07 | +1.3% | 606.5K |
KRYS | Krystal Biotech, Inc. Common Stock | $9.0b | $297.13 | -2.4% | 64.7K |
CORT | Corcept Therapeutics Inc. | $8.9b | $69.15 | -5.6% | 426.5K |
CRNX | Crinetics Pharmaceuticals, Inc. | $8.8b | $84.97 | 0.0% | N/A |
CYTK | Cytokinetics Inc. | $8.7b | $53.09 | -4.9% | 604.2K |
ARWR | Arrowhead Research Corporation | $8.4b | $44.91 | -5.7% | 773.8K |
IONS | Ionis Pharmaceuticals, Inc. Common Stock | $6.7b | $28.30 | -1.6% | 2.4M |
RYTM | Rhythm Pharmaceuticals, Inc. Common Stock | $6.0b | $108.41 | -5.5% | 486.0K |
PTCT | PTC Therapeutics, Inc. | $5.7b | $61.64 | -2.6% | 181.5K |
MIRM | Mirum Pharmaceuticals, Inc. Common Stock | $5.7b | $93.11 | -1.0% | 210.4K |
COGT | Cogent Biosciences, Inc. Common Stock | $5.4b | $27.38 | -4.5% | 607.3K |
SRRK | Scholar Rock Holding Corporation Common Stock | $5.4b | $43.00 | -0.4% | 905.5K |
APLS | Apellis Pharmaceuticals, Inc. Common Stock | $5.2b | $41.04 | +0.0% | 68.6M |
CRSP | CRISPR Therapeutics AG | $4.8b | $40.78 | -3.5% | 821.5K |
TVTX | Travere Therapeutics, Inc. Common Stock | $4.7b | $49.84 | -1.5% | 386.6K |
FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
EWTX | Edgewise Therapeutics, Inc. Common Stock | $4.1b | $43.64 | -4.7% | 515.8K |
CPRX | Catalyst Pharmaceutical Inc. | $3.8b | $31.51 | 0.0% | N/A |
LQDA | Liquidia Corporation Common Stock | $3.8b | $56.60 | -1.5% | 949.3K |
AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | $3.7b | $28.57 | -5.9% | 683.8K |
IRON | Disc Medicine, Inc. Common Stock | $3.6b | $77.70 | -2.7% | 322.0K |
TARS | Tarsus Pharmaceuticals, Inc. Common Stock | $3.4b | $78.05 | -2.7% | 267.6K |
DYN | Dyne Therapeutics, Inc. Common Stock | $3.4b | $16.52 | -3.7% | 739.1K |
VRDN | Viridian Therapeutics, Inc. Common Stock | $2.8b | $30.32 | -1.5% | 801.3K |
SLNO | Soleno Therapeutics, Inc. Common Stock | $2.7b | $53.02 | +0.0% | 1.6M |
BEAM | Beam Therapeutics Inc. Common Stock | $2.7b | $21.32 | -6.3% | 1.2M |
PHVS | Pharvaris N.V. Ordinary Shares | $2.4b | $32.86 | -2.2% | 161.8K |
COAG | Hemab Therapeutics Holdings, Inc. Common Stock | $2.3b | $40.17 | -1.3% | 189.7K |
AUPH | Aurinia Pharmaceuticals Inc | $2.2b | $15.43 | -1.8% | 382.5K |
PVLA | Palvella Therapeutics, Inc. Common Stock | $2.2b | $147.74 | -3.4% | 109.6K |
BCRX | BioCryst Pharmaceuticals Inc | $2.2b | $7.50 | -1.4% | 1.4M |
HRMY | Harmony Biosciences Holdings, Inc. Common Stock | $2.2b | $33.17 | -1.7% | 326.1K |
SRPT | Sarepta Therapeutics,, Inc. Common Stock | $2.0b | $15.20 | -5.6% | 821.8K |
XERS | Xeris Biopharma Holdings, Inc. Common Stock | $1.9b | $16.67 | -0.1% | 1.2M |
AGIO | Agios Pharmaceuticals, Inc. | $1.9b | $30.49 | -3.1% | 156.3K |
STOK | Stoke Therapeutics, Inc. Common Stock | $1.7b | $26.56 | -0.3% | 166.2K |
NTLA | Intellia Therapeutics, Inc | $1.7b | $9.89 | +1.9% | 3.4M |
ANIP | ANI Pharmaceuticals, Inc. | $1.7b | $70.79 | -0.6% | 90.8K |
QURE | uniQure N.V. | $1.7b | $22.03 | -7.2% | 370.1K |
RARE | Ultragenyx Pharmaceutical Inc. | $1.6b | $15.91 | -1.0% | 1.8M |
FBRX | Forte Biosciences, Inc. Common Stock | $1.6b | $76.98 | 0.0% | N/A |
OCUL | Ocular Therapeutix, Inc. | $1.5b | $6.03 | -4.2% | 1.7M |
ETON | Eton Pharmaceutcials, Inc. Common Stock | $1.5b | $64.38 | +0.9% | 278.1K |